dijous, 19 de juny del 2014

Medtronic, Covidien merger: Good or bad for medtech innovation?




Is the big fat marriage of MDT and COV good for Innovation? S2N Health's Amy Siegel and Tim Kofol debate the issue





Medtronic buyout holds $80M in golden parachutes for Covidien execs

By Amy Siegel & Tim Kofol, S2N Health




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/Tbr6F1

Cap comentari:

Publica un comentari a l'entrada